Summary
4 / 100 · Bulios Score
What speaks for it
None of the indicators we track stands out on the positive side.
What to watch
- Revenue fell by 64% a year over the last 3 years.
- It passes only 3 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveIs it growing?
Revenue (USD)
Diluted EPS (USD)
Revenue fell by 64% a year over the last 3 years.
Growth in detailDoes it make money?
Over the last 12 months it made a loss of $121.8K.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 3,930.5 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.